{"id":"NCT00206323","sponsor":"Baylor College of Medicine","briefTitle":"A Randomized, Placebo-controlled, Tourette Syndrome Study.","officialTitle":"A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Determine the Safety and Efficacy of Topiramate in the Treatment of Tourette Syndrome (CAPSS-176)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2004-09","primaryCompletion":"2008-12","completion":"2008-12","firstPosted":"2005-09-21","resultsPosted":"2017-11-06","lastUpdate":"2020-02-12"},"enrollment":29,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Tourette Syndrome"],"interventions":[{"type":"DRUG","name":"Topiramate (drug)","otherNames":["Topamax"]},{"type":"DRUG","name":"placebo/sugar pill","otherNames":["placebo"]}],"arms":[{"label":"placebo/sugar pill","type":"PLACEBO_COMPARATOR"},{"label":"Topiramate","type":"ACTIVE_COMPARATOR"}],"summary":"Previous studies using topiramate in Tourette subjects have shown that with the use of this medication subjects report that their tics get better. The purpose of this study is to study if topiramate improves the symptoms of Tourette syndrome, such as motor tics, or other associated symptoms such as attention or obsessive-compulsive problems.","primaryOutcome":{"measure":"Change From Baseline in Total Tic Score at Day 70","timeFrame":"baseline and Day 70","effectByArm":[{"arm":"Placebo/Sugar Pill","deltaMin":-5,"sd":9.88},{"arm":"Topiramate","deltaMin":-14.29,"sd":10.47}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0259"}]},"eligibility":{"minAge":"7 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":11,"exclusionCount":13},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["19726418"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":14},"commonTop":["headache","diarrhea","abdominal pain","drowsiness","cognitive slowing"]}}